Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Caron

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
High-quality care for all children with cancerR R G Knops, M E J L Hulscher, R P M G Hermens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2012
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivorsE Sieswerda, A Postma, E C van Dalen, et al.
Journal of Cancer Survivorship : Research and Practice|April 30, 2013
The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availabilityE Sieswerda, R L Mulder, I W E M van Dijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosisS L Knijnenburg, S Raemaekers, H van den Berg, et al.
Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.
Oncogene|August 24, 2011
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastomaE E Santo, M E Ebus, J Koster, et al.
Leukemia|September 4, 2012
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetS A Hartsink-Segers, C M Zwaan, C Exalto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2017
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patientsI R N Verly, A B P van Kuilenburg, N G G M Abeling, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 22, 2015
Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up studyR A Schoot, E A R Theunissen, O Slater, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcomaS C Clement, R A Schoot, O Slater, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
High-quality care for all children with cancerR R G Knops, M E J L Hulscher, R P M G Hermens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2012
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivorsE Sieswerda, A Postma, E C van Dalen, et al.
Journal of Cancer Survivorship : Research and Practice|April 30, 2013
The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availabilityE Sieswerda, R L Mulder, I W E M van Dijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosisS L Knijnenburg, S Raemaekers, H van den Berg, et al.
Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.
Oncogene|August 24, 2011
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastomaE E Santo, M E Ebus, J Koster, et al.
Leukemia|September 4, 2012
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetS A Hartsink-Segers, C M Zwaan, C Exalto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2017
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patientsI R N Verly, A B P van Kuilenburg, N G G M Abeling, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|August 22, 2015
Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up studyR A Schoot, E A R Theunissen, O Slater, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcomaS C Clement, R A Schoot, O Slater, et al.
Pageof 6